Exalt Diagnostics Overview
- Year Founded
-
2012
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Exalt Diagnostics General Information
Description
Developer of photonic crystal enhanced fluorescence technology designed to introduce high sensitivity, and highly portable biosensor detection instrumentation to point of care clinics and to consumers. The company's FluoroBoost technology measures the presence and concentration of dozens of proteins circulating inside an individual and offers nanostructured photonic crystal chips and detection instrument that boost the output of fluorescent light emitters used to label DNA and protein molecules present in blood samples, enabling doctors to identify the presence of diseases, such as cancer, that may not become evident until serious symptoms occur.
Contact Information
Website
www.exaltdiagnostics.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Commercial Products
Other Industries
Biotechnology
Primary Office
- 60 Hazelwood Drive
- Champaign, IL 61820
- United States
Exalt Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 01-Aug-2017 | Completed | Out of Business | |||
| 3. Grant | 15-Sep-2013 | Completed | Startup | |||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Accelerator/Incubator | Completed | Startup |